WESTON, Fla., Dec. 30 /PRNewswire-FirstCall/ -- American Scientific Resources, Inc. (the "Company") (Pink Sheets: ASFX), has been informed by Pink OTC Markets Inc. ("Pink Sheets") that the Caveat Emptor designation has been removed from the Company's quotation, and that the full designation of "Pink Sheets Current Information" has now been assigned. Full details may be found at www.pinksheets.com where the new upgraded designation can be viewed.
Dr. Christopher F. Tirotta, CEO of American Scientific Resources, Inc. comments, "Naturally we are very pleased with this significant event, and to have our status upgraded at the Pink Sheets. This reflects the considerable efforts we have made to become a fully reporting company and enhance all our reporting and disclosures to the highest level. We thank all our shareholders for their continued support, and we look forward to 2010."
The Company urges shareholders, broker dealers and other interested parties to visit www.pinksheets.com for confirmation and further information.
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is a holding company for wholly owned subsidiary, Kidz-Med. The Company's objective is to design innovative health and safety technologies, develop intellectual property, and to locate, acquire, introduce and promote innovative health and safety products that are successfully sold abroad. For more information, visit the corporate web site at www.americansci.com and the Company's subsidiary, Kidz-Med at www.kidzmed.com.
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact American Scientific Resources Investor Relations E-mail IR@americansci.com Or call 561-948-4863
SOURCE American Scientific Resources, Inc.
|SOURCE American Scientific Resources, Inc.|
Copyright©2009 PR Newswire.
All rights reserved